These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24226313)

  • 41. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
    Bath P
    Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antihypertensive drugs and their effects on cerebral circulation].
    Nagao T; Fujishima M
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():237-40. PubMed ID: 11028331
    [No Abstract]   [Full Text] [Related]  

  • 43. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

  • 44. [Fundamental research--a basis for the synthesis of new hypotensive drugs].
    Almazov VA; Shliakhto EV
    Kardiologiia; 1991 Dec; 31(12):24-8. PubMed ID: 1687751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertension control in chronic kidney disease: don't miss the forest for the trees.
    Ong HT; Ong LM; Ho JJ
    Med J Malaysia; 2012 Aug; 67(4):359-62. PubMed ID: 23082441
    [No Abstract]   [Full Text] [Related]  

  • 46. [Efficacy of monotherapy with 15 antihypertensive agents in treating essential hypertension assessed by 24-hour ambulatory blood pressure monitoring].
    Hua CX; Hua L; Li N; Wang L; Pang HM; Ming GH; Huang Y; Cheng XR; Liu H; Wu Y; Xu L; Kang J; Xu ZM; Li YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Dec; 29(6):792-6. PubMed ID: 18595261
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Clinical trials on protective efficacy of antihypertensive agents for organ damage due to diabetes mellitus complicated with hypertension].
    Higashiura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():623-7. PubMed ID: 15171446
    [No Abstract]   [Full Text] [Related]  

  • 48. ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?
    Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD
    Aust Fam Physician; 2013 Sep; 42(9):634-8. PubMed ID: 24024224
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 50 years of thiazides: should thiazide diuretics be considered third-line hypertension treatment?
    Brown A; Captain B
    Am J Ther; 2011 Nov; 18(6):e244-54. PubMed ID: 21436766
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug therapy for hypertension: where we are, and where we might be heading.
    Wilson TW; Quest DW
    Can J Public Health; 1994; 85 Suppl 2():S48-50. PubMed ID: 7804950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Calcium channel blockers in the prevention of end stage renal disease: a review.
    Derwa A; Peeters P; Vanholder R
    Acta Clin Belg; 2004; 59(1):44-56. PubMed ID: 15065696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. New antihypertensive drugs. Angiotensin converting enzyme inhibitors and calcium antagonists.
    Johnston CI
    Aust Fam Physician; 1984 Apr; 13(4):278-83. PubMed ID: 6331357
    [No Abstract]   [Full Text] [Related]  

  • 54. Follow-up of Antihypertensive Therapy Improves Blood Pressure Control: Results of HYT (HYperTension survey) Follow-up.
    Fici F; Seravalle G; Koylan N; Nalbantgil I; Cagla N; Korkut Y; Quarti-Trevano F; Makel W; Grassi G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):289-296. PubMed ID: 28497339
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interactions between antihypertensive drugs].
    Takagi M; Matsuoka H
    Nihon Rinsho; 1992 May; 50 Suppl():23-27. PubMed ID: 1355126
    [No Abstract]   [Full Text] [Related]  

  • 57. Combination antihypertensive therapy in the treatment of diabetic nephropathy.
    Boner G; Cao Z; Cooper ME
    Diabetes Technol Ther; 2002; 4(3):313-21. PubMed ID: 12165170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of antihypertensive drugs on the fetus.
    Rosenthal T; Oparil S
    J Hum Hypertens; 2002 May; 16(5):293-8. PubMed ID: 12082488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A review of chemical therapies for treating diabetic hypertension.
    Sarafidis PA; Alexandrou ME; Ruilope LM
    Expert Opin Pharmacother; 2017 Jun; 18(9):909-923. PubMed ID: 28480805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Salt, the renin-angiotensin-aldosterone system and resistant hypertension.
    Shimosawa T
    Hypertens Res; 2013 Aug; 36(8):657-60. PubMed ID: 23912973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.